About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 464921, 8 pages
http://dx.doi.org/10.1155/2013/464921
Review Article

Oxidation of Marine Omega-3 Supplements and Human Health

1Liggins Institute, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
2Gravida: National Centre for Growth and Development, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand

Received 15 February 2013; Revised 4 April 2013; Accepted 9 April 2013

Academic Editor: Gabriella Calviello

Copyright © 2013 Benjamin B. Albert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Barnes, B. Bloom, and R. L. Nahin, Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2008.
  2. P. M. Barnes, E. Powell-Griner, K. McFann, and R. L. Nahin, “Complementary and alternative medicine use among adults: United States, 2002,” Advance Data, no. 343, pp. 1–19, 2004. View at Scopus
  3. P. C. Calder, “n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored,” Clinical Science, vol. 107, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. C. Calder, “Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?” British Journal of Clinical Pharmacology, vol. 75, pp. 645–662, 2013.
  5. J. E. Karr, J. E. Alexander, and R. G. Winningham, “Omega-3 polyunsaturated fatty acids and cognition throughout the lifespan: a review,” Nutritional Neuroscience, vol. 14, no. 5, pp. 216–225, 2011. View at Publisher · View at Google Scholar
  6. N. S. Kalupahana, K. J. Claycombe, and N. Moustaid-Moussa, “(n-3) fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights,” Advances in Nutrition, vol. 2, pp. 304–316, 2011. View at Publisher · View at Google Scholar
  7. N. Matsuo, “Studies on the toxicity of fish oil,” The Journal of Biochemistry, vol. 41, pp. 481–487, 1954.
  8. F. Shahidi and Y. Zhong, “Lipid oxidation and improving the oxidative stability,” Chemical Society Reviews, vol. 39, no. 11, pp. 4067–4079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. I. F. F. Benzie, “Lipid peroxidation: a review of causes, consequences, measurement and dietary influences,” International Journal of Food Sciences and Nutrition, vol. 47, no. 3, pp. 233–261, 1996. View at Scopus
  10. A. Barden, E. Mas, P. Henry et al., “The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function,” Free Radical Research, vol. 45, no. 4, pp. 469–476, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Esterbauer, “Cytotoxicity and genotoxicity of lipid-oxidation products,” American Journal of Clinical Nutrition, vol. 57, no. 5, pp. 779S–785S, 1993. View at Scopus
  12. C. S. Pak, Stability and Quality of Fish Oil During Typical Domestic Application, United Nations University, Reykjavik, Iceland, 2005, http://www.unuftp.is/static/fellows/document/pak05prf.pdf.
  13. P. C. Zuta, B. K. Simpson, X. Zhao, and L. Leclerc, “The effect of α-tocopherol on the oxidation of mackerel oil,” Food Chemistry, vol. 100, no. 2, pp. 800–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. W. Thomas, F. J. G. M. van Kuijk, E. A. Dratz, and R. J. Stephens, “Quantitative determination of hydroxy fatty acids as an indicator of in vivo lipid peroxidation: gas chromatography-mass spectrometry methods,” Analytical Biochemistry, vol. 198, no. 1, pp. 104–111, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. H. C. Yee, H. J. Helbock, D. W. Chyu, and B. N. Ames, “Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry,” Analytical Biochemistry, vol. 220, no. 2, pp. 391–396, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. X. P. Luo, M. Yazdanpanah, N. Bhooi, and D. C. Lehotay, “Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry,” Analytical Biochemistry, vol. 228, no. 2, pp. 294–298, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. A. E. Barden, K. D. Croft, T. Durand, A. Guy, M. J. Mueller, and T. A. Mori, “Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men,” Journal of Nutrition, vol. 139, no. 10, pp. 1890–1895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. European Pharmacopoeia Commission, “European Pharmacopoeia 5.0,” Council of Europe, 2005, http://lib.njutcm.edu.cn/yaodian/ep/EP5.0/index.html.
  19. EFSA Panel on Biological Hazards (BIOHAZ), “Scientific opinion on fish oil for human consumption. Food hygiene, including rancidity,” EFSA Journal, vol. 8, no. 10, p. 48, 2010.
  20. Global Organization for EPA and DHA Omega-3, “GOED Voluntary Monograph (v.4),” 2012, http://www.goedomega3.com/images/stories/files/goedmonograph.pdf.
  21. Health Canada, “Monograph: Fish Oil,” 2009, http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=88&lang=eng.
  22. USA Council for Responsible Nutrition, “Voluntary Monograph: Omega-3 DHA, Omega-3 EPA, Omega-3 DHA & EPA,” 2006, http://www.crnusa.org/pdfs/O3FINALMONOGRAPHdoc.pdf.
  23. B. L. Halvorsen and R. Blomhoff, “Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements,” Food and Nutrition Research, vol. 55, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Kolanowski, “Omega-3 LC PUFA contents and oxidative stability of encapsulated fish oil dietary supplements,” International Journal of Food Properties, vol. 13, no. 3, pp. 498–511, 2010. View at Publisher · View at Google Scholar
  25. “Something fishy? Omega-3 supplements test,” Consumer, vol. 469, pp. 12–15, 2007.
  26. C. Fierens and J. Corthout, “Omega-3 fatty acid preparations—a comparative study,” Journal de Pharmacie de Belgique, vol. 62, no. 4, pp. 115–119, 2007. View at Scopus
  27. C. M. Fantoni, A. P. Cuccio, and D. Barrera-Arellano, “Brazilian encapsulated fish oils: oxidative stability and fatty acid composition,” Journal of the American Oil Chemists' Society, vol. 73, no. 2, pp. 251–253, 1996. View at Scopus
  28. M. H. Davidson, “Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids,” American Journal of Cardiology, vol. 98, no. 4, pp. 27–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. De Caterina, R. Madonna, R. Zucchi, and M. T. La Rovere, “Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside,” American Heart Journal, vol. 146, no. 3, pp. 420–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Y. Oh, S. Talukdar, E. J. Bae et al., “GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects,” Cell, vol. 142, no. 5, pp. 687–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Richard, K. Kefi, U. Barbe, P. Bausero, and F. Visioli, “Polyunsaturated fatty acids as antioxidants,” Pharmacological Research, vol. 57, no. 6, pp. 451–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. E. Feller, K. Gawrisch, and A. D. MacKerell Jr., “Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties,” Journal of the American Chemical Society, vol. 124, no. 2, pp. 318–326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Haglund, R. Luostarinen, R. Wallin, L. Wibell, and T. Saldeen, “The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E,” Journal of Nutrition, vol. 121, no. 2, pp. 165–169, 1991. View at Scopus
  34. A. Mishra, A. Chaudhary, and S. Sethi, “Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 9, pp. 1621–1627, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Brooks, E. S. Musiek, T. R. Koestner, et al., “The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation,” Journal of Neurochemistry, vol. 119, no. 3, pp. 604–616, 2011. View at Publisher · View at Google Scholar
  36. I. Staprans, J. H. Rapp, X. M. Pan, K. Y. Kim, and K. R. Feingold, “Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum,” Arteriosclerosis and Thrombosis, vol. 14, no. 12, pp. 1900–1905, 1994. View at Scopus
  37. M. Ahotupa, J. P. Suomela, T. Vuorimaa, and T. Vasankari, “Lipoprotein-specific transport of circulating lipid peroxides,” Annals of Medicine, vol. 42, no. 7, pp. 521–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. P. Suomela, M. Ahotupa, O. Sjövall, J. P. Kurvinen, and H. Kallio, “Diet and lipoprotein oxidation: analysis of oxidized triacylglycerols in pig lipoproteins,” Lipids, vol. 39, no. 7, pp. 639–647, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. J. T. Salonen, S. Ylä-Herttuala, R. Yamamoto et al., “Autoantibody against oxidised LDL and progression of carotid atherosclerosis,” The Lancet, vol. 339, no. 8798, pp. 883–887, 1992. View at Scopus
  40. K. Kanazawa and H. Ashida, “Dietary hydroperoxides of linoleic acid decompose to aldehydes in stomach before being absorbed into the body,” Biochimica et Biophysica Acta, vol. 1393, no. 2-3, pp. 349–361, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Vidyasagar, N. Karunakar, M. S. Reddy, K. Rajnaranyana, T. Surender, and D. R. Krishna, “Oxidative stress and antioxidant status in acute organophosphorous insecticide poisoning,” Indian Journal of Pharmacology, vol. 36, no. 2, pp. 76–79, 2004. View at Scopus
  42. H. Bartsch and J. Nair, “Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair,” Langenbeck's Archives of Surgery, vol. 391, no. 5, pp. 499–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. L. M. Sayre, D. A. Zelasko, P. L. R. Harris, G. Perry, R. G. Salomon, and M. A. Smith, “4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease,” Journal of Neurochemistry, vol. 68, no. 5, pp. 2092–2097, 1997. View at Scopus
  44. R. van den Berg, G. R. M. M. Haenen, H. van den Berg, and A. Bast, “Transcription factor NF-κB as a potential biomarker for oxidative stress,” British Journal of Nutrition, vol. 86, no. 1, pp. S121–S127, 2001. View at Scopus
  45. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Scopus
  47. G. M. Chisolm and D. Steinberg, “The oxidative modification hypothesis of atherogenesis: an overview,” Free Radical Biology and Medicine, vol. 28, no. 12, pp. 1815–1826, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. J. L. Goldstein, Y. K. Ho, S. K. Basu, and M. S. Brown, “Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 1, pp. 333–337, 1979. View at Scopus
  49. J. Thiery and D. Seidel, “Fish oil feeding results in an enhancement of cholesterol-induced atherosclerosis in rabbits,” Atherosclerosis, vol. 63, no. 1, pp. 53–56, 1987. View at Scopus
  50. B. Rauch, R. Schiele, S. Schneider et al., “OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction,” Circulation, vol. 122, no. 21, pp. 2152–2159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. L. A. Piche, H. H. Draper, and P. D. Cole, “Malondialdehyde excretion by subjects consuming cod liver oil vs a concentrate of n-3 fatty acids,” Lipids, vol. 23, no. 4, pp. 370–371, 1988. View at Scopus
  52. S. H. Cho and Y. S. Choi, “Lipid peroxidation and antioxidant status is affected by different vitamin E levels when feeding fish oil,” Lipids, vol. 29, no. 1, pp. 47–52, 1994. View at Scopus
  53. M. J. Gonzalez, J. I. Gray, R. A. Schemmel, L. Dugan, and C. W. Welsch, “Lipid peroxidation products are elevated in fish oil diets even in the presence of added antioxidants,” Journal of Nutrition, vol. 122, no. 11, pp. 2190–2195, 1992. View at Scopus
  54. A. K. Basu and L. J. Marnett, “Unequivocal demonstration that malondialdehyde is a mutagen,” Carcinogenesis, vol. 4, no. 3, pp. 331–333, 1983. View at Scopus
  55. L. J. Marnett, “Lipid peroxidation—DNA damage by malondialdehyde,” Mutation Research, vol. 424, no. 1-2, pp. 83–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Wang, K. Dhingra, W. N. Hittelman, J. G. Liehr, M. de Andrade, and D. Li, “Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues,” Cancer Epidemiology Biomarkers and Prevention, vol. 5, no. 9, pp. 705–710, 1996. View at Scopus
  57. I. Ottestad, G. Vogt, K. Retterstøl, et al., “Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial,” British Journal of Nutrition, vol. 108, no. 2, pp. 315–326, 2012. View at Publisher · View at Google Scholar
  58. R. Villegas, Y. B. Xiang, T. Elasy et al., “Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women,” American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 543–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Iso, M. Kobayashi, J. Ishihara et al., “Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) study cohort I,” Circulation, vol. 113, no. 2, pp. 195–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Sekikawa, H. Ueshima, T. Kadowaki et al., “Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-world war II birth cohort,” American Journal of Epidemiology, vol. 165, no. 6, pp. 617–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Kromhout, E. B. Bosschieter, and C. de Lezenne Coulander, “The inverse relation between fish consumption and 20-year mortality from coronary heart disease,” The New England Journal of Medicine, vol. 312, no. 19, pp. 1205–1209, 1985. View at Scopus
  62. H. O. Bang, J. Dyerberg, and A. B. Nielsen, “Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos,” The Lancet, vol. 1, no. 7710, pp. 1143–1145, 1971. View at Scopus
  63. C. M. Albert, H. Campos, M. J. Stampfer et al., “Blood levels of long-chain n-3 fatty acids and the risk of sudden death,” The New England Journal of Medicine, vol. 346, no. 15, pp. 1113–1118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. M. L. Daviglus, J. Stamler, A. J. Orencia et al., “Fish consumption and the 30-year risk of fatal myocardial infarction,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1046–1053, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Djoussé, M. L. Biggs, R. N. Lemaitre, et al., “Plasma omega-3 fatty acids and incident diabetes in older adults,” The American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 527–533, 2011. View at Publisher · View at Google Scholar
  66. J. C. Liu, S. M. Conklin, S. B. Manuck, J. K. Yao, and M. F. Muldoon, “Long-chain omega-3 fatty acids and blood pressure,” American Journal of Hypertension, vol. 24, no. 10, pp. 1121–1126, 2011. View at Publisher · View at Google Scholar
  67. D. S. Siscovick, T. E. Raghunathan, I. King et al., “Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest,” Journal of the American Medical Association, vol. 274, no. 17, pp. 1363–1367, 1995. View at Scopus
  68. W. S. Harris, “n-3 fatty acids and lipoproteins: comparison of results from human and animal studies,” Lipids, vol. 31, no. 3, pp. 243–252, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Kestin, P. Clifton, G. B. Belling, and P. J. Nestel, “n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants,” American Journal of Clinical Nutrition, vol. 51, no. 6, pp. 1028–1034, 1990. View at Scopus
  70. C. Dawczynski, L. Martin, A. Wagner, and G. Jahreis, “N-3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: a double-blind, cross-over study,” Clinical Nutrition, vol. 29, no. 5, pp. 592–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Svensson, E. B. Schmidt, K. A. Jørgensen, and J. H. Christensen, “The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study,” Nephrology Dialysis Transplantation, vol. 23, no. 9, pp. 2918–2924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. C. von Schacky, “A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels,” Vascular Health and Risk Management, vol. 2, no. 3, pp. 251–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. P. J. Nestel, “Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol,” American Journal of Clinical Nutrition, vol. 43, no. 5, pp. 752–757, 1986. View at Scopus
  74. J. Dyerberg, J. H. Christensen, D. Eskesen, A. Astrup, and S. Stender, “Trans, and n-3 polyunsaturated fatty acids and vascular function—a yin yang situation?” Atherosclerosis Supplements, vol. 7, no. 2, pp. 33–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. G. K. Paschos, F. Magkos, D. B. Panagiotakos, V. Votteas, and A. Zampelas, “Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients,” European Journal of Clinical Nutrition, vol. 61, no. 10, pp. 1201–1206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan, “Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials,” Circulation, vol. 112, no. 13, pp. 1945–1952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. J. H. Christensen, P. Gustenhoff, E. Korup et al., “Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial,” British Medical Journal, vol. 312, no. 7032, pp. 677–678, 1996. View at Scopus
  78. J. H. Christensen, M. S. Christensen, J. Dyerberg, and E. B. Schmidt, “Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids,” American Journal of Clinical Nutrition, vol. 70, no. 3, pp. 331–337, 1999. View at Scopus
  79. T. A. Mori, L. J. Beilin, V. Burke, J. Morris, and J. Ritchie, “Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 2, pp. 279–286, 1997. View at Scopus
  80. L. Axelrod, J. Camuso, E. Williams, K. Kleinman, E. Briones, and D. Schoenfeld, “Effects of a small quantity of ω-3 fatty acids on cardiovascular risk factors in NIDDM: a randomized, prospective, double-blind, controlled study,” Diabetes Care, vol. 17, no. 1, pp. 37–44, 1994. View at Scopus
  81. F. Khan, K. Elherik, C. Bolton-Smith et al., “The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects,” Cardiovascular Research, vol. 59, no. 4, pp. 955–962, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Thies, J. M. C. Garry, P. Yaqoob et al., “Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial,” The Lancet, vol. 361, no. 9356, pp. 477–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Marchioli, F. Barzi, E. Bomba et al., “Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione,” Circulation, vol. 105, no. 16, pp. 1897–1903, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. M. L. Burr, A. M. Fehily, J. F. Gilbert et al., “Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART),” The Lancet, vol. 2, no. 8666, pp. 757–761, 1989. View at Scopus
  85. R. B. Singh, M. A. Niaz, J. P. Sharma, R. Kumar, V. Rastogi, and M. Moshiri, “Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival—4,” Cardiovascular Drugs and Therapy, vol. 11, no. 3, pp. 485–491, 1997. View at Publisher · View at Google Scholar · View at Scopus
  86. J. M. Geleijnse, E. J. Giltay, D. E. Grobbee, A. R. T. Donders, and F. J. Kok, “Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials,” Journal of Hypertension, vol. 20, no. 8, pp. 1493–1499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. M. C. Morris, F. Sacks, and B. Rosner, “Does fish oil lower blood pressure? A meta-analysis of controlled trials,” Circulation, vol. 88, no. 2, pp. 523–533, 1993. View at Scopus
  88. E. M. Balk, A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau, “Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review,” Atherosclerosis, vol. 189, no. 1, pp. 19–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Bosch, H. C. Gerstein, G. R. Dagenais, et al., “n-3 fatty acids and cardiovascular outcomes in patients with dysglycaemia,” The New England Journal of Medicine, vol. 367, no. 4, pp. 309–318, 2012. View at Publisher · View at Google Scholar
  90. M. Yokoyama, H. Origasa, M. Matsuzaki et al., “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis,” The Lancet, vol. 369, no. 9567, pp. 1090–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Wang, W. S. Harris, M. Chung et al., “n-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 5–17, 2006. View at Scopus
  92. E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, “Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 308, no. 10, pp. 1024–1033, 2012. View at Publisher · View at Google Scholar
  93. Y. Nakamura, H. Ueshima, T. Okamura et al., “Association between fish consumption and all-cause and cause-specific mortality in Japan: NIPPON DATA80, 1980–99,” American Journal of Medicine, vol. 118, no. 3, pp. 239–245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Awada, A. Meynier, C. O. Soulage, et al., “n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice,” Nutrition & Metabolism, vol. 10, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  95. Ghafoorunissa, A. Ibrahim, L. Rajkumar, and V. Acharya, “Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats,” Journal of Nutrition, vol. 135, no. 11, pp. 2634–2638, 2005. View at Scopus
  96. Y. B. Lombardo, G. Hein, and A. Chicco, “Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity,” Lipids, vol. 42, no. 5, pp. 427–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. A. González-Périz, R. Horrillo, N. Ferré et al., “Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins,” The FASEB Journal, vol. 23, no. 6, pp. 1946–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus